Literature DB >> 14676943

Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state.

C H Saely, S Aczel, T Marte, P Langer, H Drexel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14676943     DOI： 10.1007/s00125-003-1274-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Diabetes and coronary heart disease.

Authors:  L A Simons; J Simons
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

2.  Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies.

Authors:  Josie M M Evans; Jixian Wang; Andrew D Morris
Journal:  BMJ       Date:  2002-04-20

3.  Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis.

Authors:  H Drexel; F W Amann; J Beran; K Rentsch; R Candinas; J Muntwyler; A Luethy; T Gasser; F Follath
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

4.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

5.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321
  5 in total
  10 in total

1.  Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges.

Authors:  Syed Y Naqvi; Steven D Wittlin; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2018-02-05       Impact factor: 5.952

2.  Carotid and cerebrovascular disease in symptomatic patients with type 2 diabetes: assessment of prevalence and plaque morphology by dual-source computed tomography angiography.

Authors:  Ci He; Zhi-Gang Yang; Zhi-Gang Chu; Zhi-Hui Dong; Heng Shao; Wen Deng; Jing Chen; Li-Qing Peng; Si-Shi Tang; Jia-He Xiao
Journal:  Cardiovasc Diabetol       Date:  2010-12-18       Impact factor: 9.951

3.  Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus.

Authors:  Christine Gyldenkerne; Kevin Kris Warnakula Olesen; Morten Madsen; Troels Thim; Lisette Okkels Jensen; Bent Raungaard; Henrik Toft Sørensen; Hans Erik Bøtker; Michael Maeng
Journal:  Clin Epidemiol       Date:  2019-05-23       Impact factor: 4.790

4.  Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study.

Authors:  Kevin Kris Warnakula Olesen; Morten Madsen; Christine Gyldenkerne; Pernille Gro Thrane; Troels Thim; Lisette Okkels Jensen; Hans Erik Bøtker; Henrik Toft Sørensen; Michael Maeng
Journal:  Cardiovasc Diabetol       Date:  2021-01-21       Impact factor: 9.951

5.  Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry.

Authors:  Kevin Kris Warnakula Olesen; Christine Gyldenkerne; Troels Thim; Reimar Wernich Thomsen; Michael Maeng
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01

6.  Estimation and comparison of salivary flow rate and its composition in diabetic patients and nondiabetic patients: A pilot study.

Authors:  S Dhanarathna; Nadeem Jeddy; B Sabarinath; G B Protyusha
Journal:  J Oral Maxillofac Pathol       Date:  2021-08-31

7.  Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.

Authors:  Lukas Sprenger; Arthur Mader; Barbara Larcher; Maximilian Mächler; Alexander Vonbank; Daniela Zanolin-Purin; Andreas Leiherer; Axel Muendlein; Heinz Drexel; Christoph H Saely
Journal:  BMJ Open Diabetes Res Care       Date:  2021-11

8.  Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models.

Authors:  Sk Mastan; K Eswar Kumar
Journal:  Diabetol Metab Syndr       Date:  2009-10-09       Impact factor: 3.320

9.  Noninvasive assessment of the carotid and cerebrovascular atherosclerotic plaques by multidetector CT in type-2 diabetes mellitus patients with transient ischemic attack or stroke.

Authors:  Ci He; Ming Gu; Rui Jiang; Jian-Hao Li
Journal:  Diabetol Metab Syndr       Date:  2013-02-26       Impact factor: 3.320

10.  Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose-insulin homeostasis in animal models.

Authors:  S K Mastan; K Eswar Kumar
Journal:  J Exp Pharmacol       Date:  2009-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.